Iovance Biotherapeutics, Inc. (IOVA)

CIK 1425205 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Iovance Biotherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 202640001104659-26-106750
Sep 10, 202640001104659-26-106752
Sep 10, 202640001104659-26-106748
Sep 3, 202640001104659-26-105101
Sep 3, 202640001104659-26-105099
Sep 3, 202640001104659-26-105100
Aug 12, 202640001104659-26-095040
Aug 10, 202640001104659-26-093482
Aug 7, 2026SCHEDULE 13G0000093751-26-000486
Aug 6, 20268-K0001104659-26-091619
Aug 6, 202610-Q0001104659-26-091716
Aug 6, 20268-K0001104659-26-092145
Jul 28, 2026SCHEDULE 13G/A0002012383-26-002600
Jul 2, 20268-K0001104659-26-080409
Jun 18, 202640001104659-26-075861
Jun 18, 202640001104659-26-075858
Jun 18, 202640001104659-26-075856
Jun 18, 2026S-80001104659-26-075832
Jun 18, 2026S-80001104659-26-075831
Jun 18, 202640001104659-26-075863
Jun 18, 2026S-3ASR0001104659-26-075778
Jun 18, 202640001104659-26-075854
Jun 10, 20268-K0001104659-26-072408
Jun 9, 202640001104659-26-071895
Jun 9, 202640001104659-26-071897